Jetstream XC Device for Treatment of Long Viabahn Stents Occlusions in the Superficial Femoral Artery: A Report of Two Cases

Repeated restenotic events are common in superficial femoral artery and as of late, Viabahn stent grafts have been FDA (U.S. Food & Drug Administration) approved. Viabahn have been particularly attractive given that they provided a physical barrier for the development of neointimal hyperplasia....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae-Hoon, Chavarria, Nelson, Dahal, Khagendra, Azrin, Michael, Lee, Juyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835424/
https://www.ncbi.nlm.nih.gov/pubmed/29515712
http://dx.doi.org/10.3400/avd.cr.17-00028
Descripción
Sumario:Repeated restenotic events are common in superficial femoral artery and as of late, Viabahn stent grafts have been FDA (U.S. Food & Drug Administration) approved. Viabahn have been particularly attractive given that they provided a physical barrier for the development of neointimal hyperplasia. This particular feature however, also underscores one of the main limitations of the therapy; providing a physical barrier of collateral circulation and predisposing to acute limb ischemia. Viabahn endograft thrombosis is characterized by stent edge stenosis and endograft thrombosis. Here we present 2 cases of Viabahn graft thrombosis successfully treated with the Jetstream atherectomy device, a rotational cutter with aspiration capacity.

Ejemplares similares